Revance Therapeutics shares owned by Freestone Capital Holdings
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Freestone Capital Holdings
from 13F filings
Historical chart of Freestone Capital Holdings investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Freestone Capital Holdings consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Freestone Capital Holdings
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $207k | 18k | 11.47 |
| 2023-06-30 | $456k | 18k | 25.31 |
| 2023-03-31 | $580k | 18k | 32.21 |
| 2022-12-31 | $333k | 18k | 18.46 |
| 2022-09-30 | $817k | 30k | 27.00 |
| 2022-06-30 | $418k | 30k | 13.82 |
| 2022-03-31 | $578k | 30k | 19.49 |
| 2021-12-31 | $484k | 30k | 16.32 |
| 2021-09-30 | $816k | 29k | 27.87 |
| 2021-06-30 | $868k | 29k | 29.65 |
| 2021-03-31 | $818k | 29k | 27.94 |
| 2020-12-31 | $830k | 29k | 28.34 |
More positions owned by Freestone Capital Holdings
View all positions for Freestone Capital Holdings